These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 25720642)

  • 1. Thymic Function during 12 Months of Highly Active Antiretroviral Therapy in Thai HIV-Infected Patients with Normal and Slow Immune Recovery.
    Kingkeow D; Srithep S; Praparattanapan J; Supparatpinyo K; Pornprasert S
    Jpn J Infect Dis; 2015; 68(5):353-6. PubMed ID: 25720642
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thymic volume is associated independently with the magnitude of short- and long-term repopulation of CD4+ T cells in HIV-infected adults after highly active antiretroviral therapy (HAART).
    Ruiz-Mateos E; Rubio A; Vallejo A; De la Rosa R; Sanchez-Quijano A; Lissen E; Leal M
    Clin Exp Immunol; 2004 Jun; 136(3):501-6. PubMed ID: 15147352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in levels of T cell subpopulations to monitor the response to antiretroviral therapy among HIV-1-infected patients during two years of HIV-1 replication suppression.
    Zhang JC; Zhang HJ; Li Y; Jing D; Liu Q; Zhao K; Liu QQ; Zhuang Y; Kang WZ; Sun YT
    Scand J Infect Dis; 2013 May; 45(5):368-77. PubMed ID: 23186319
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV-infected patients with a large thymus maintain higher CD4 counts in a 5-year follow-up study of patients treated with highly active antiretroviral therapy.
    Kolte L; Ryder LP; Albrecht-Beste E; Jensen FK; Nielsen SD
    Scand J Immunol; 2009 Dec; 70(6):608-13. PubMed ID: 19906203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of thymic function-related markers to predict early CD4 T-cell repopulation in adult HIV-infected patients on HAART.
    Ruiz-Mateos E; de la Rosa R; Soriano N; Martinez-Moya M; Rubio A; Sánchez-Quijano A; Lissen E; Leal M
    Antivir Ther; 2003 Aug; 8(4):289-94. PubMed ID: 14518697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in T cell receptor excision DNA circle (TREC) levels in HIV type 1-infected subjects pre- and post-highly active antiretroviral therapy.
    Touloumi G; Pantazis N; Karafoulidou A; Mandalaki T; Goedert JJ; Kostrikis LG; Hatzakis A
    AIDS Res Hum Retroviruses; 2004 Jan; 20(1):47-54. PubMed ID: 15000698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative analysis of T-cell turnover and homeostatic parameters in HIV-infected patients with discordant immune-virological responses to HAART.
    Marchetti G; Gori A; Casabianca A; Magnani M; Franzetti F; Clerici M; Perno CF; Monforte Ad; Galli M; Meroni L
    AIDS; 2006 Aug; 20(13):1727-36. PubMed ID: 16931937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between larger thymic size and higher thymic output in human immunodeficiency virus-infected patients receiving highly active antiretroviral therapy.
    Kolte L; Dreves AM; Ersbøll AK; Strandberg C; Jeppesen DL; Nielsen JO; Ryder LP; Nielsen SD
    J Infect Dis; 2002 Jun; 185(11):1578-85. PubMed ID: 12023763
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thymic function in HIV-infection.
    Kolte L
    Dan Med J; 2013 Apr; 60(4):B4622. PubMed ID: 23651726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thymic output during initial highly active antiretroviral therapy (HAART) and during HAART supplementation with interleukin 2 and/or with HIV type 1 immunogen (Remune).
    Pido-Lopez J; Burton C; Hardy G; Pires A; Sullivan A; Gazzard B; Aspinall R; Gotch F; Imami N
    AIDS Res Hum Retroviruses; 2003 Feb; 19(2):103-9. PubMed ID: 12639245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD4+ cell count 6 years after commencement of highly active antiretroviral therapy in persons with sustained virologic suppression.
    Moore RD; Keruly JC
    Clin Infect Dis; 2007 Feb; 44(3):441-6. PubMed ID: 17205456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of CD4+ T-lymphocyte counts and new thymic emigrants in HIV-infected children during successful highly active antiretroviral therapy.
    Saitoh A; Singh KK; Sandall S; Powell CA; Fenton T; Fletcher CV; Hsia K; Spector SA
    J Allergy Clin Immunol; 2006 Apr; 117(4):909-15. PubMed ID: 16630951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the impact of highly active antiretroviral therapy on immune recovery in antiretroviral naive patients.
    Al-Harthi L; Voris J; Patterson BK; Becker S; Eron J; Smith KY; D'Amico R; Mildvan D; Snidow J; Pobiner B; Yau L; Landay A
    HIV Med; 2004 Jan; 5(1):55-65. PubMed ID: 14731171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV-infected children with moderate/severe immune-suppression: changes in the immune system after highly active antiretroviral therapy.
    Resino S; Galán I; Pérez A; León JA; Seoane E; Gurbindo D; Muñoz-Fernandez MA
    Clin Exp Immunol; 2004 Sep; 137(3):570-7. PubMed ID: 15320908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV-1-infected children on HAART: immunologic features of three different levels of viral suppression.
    Zaccarelli-Filho CA; Ono E; Machado DM; Brunialti M; Succi RC; Salomão R; Kallás EG; de Moraes-Pinto MI
    Cytometry B Clin Cytom; 2007 Jan; 72(1):14-21. PubMed ID: 17041945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune reconstitution in HIV-1-infected children on antiretroviral therapy: role of thymic output and viral fitness.
    Ometto L; De Forni D; Patiri F; Trouplin V; Mammano F; Giacomet V; Giaquinto C; Douek D; Koup R; De Rossi A
    AIDS; 2002 Apr; 16(6):839-49. PubMed ID: 11919485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of baseline CD4(+) T cell counts on the efficacy of nevirapine-based highly active antiretroviral therapy in Chinese HIV/AIDS patients: a prospective, multicentric study.
    Liu ZY; Guo FP; Han Y; Qiu ZF; Zuo LY; Li YL; Li TS
    Chin Med J (Engl); 2009 Oct; 122(20):2497-502. PubMed ID: 20079166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Naïve T-cell dynamics in human immunodeficiency virus type 1 infection: effects of highly active antiretroviral therapy provide insights into the mechanisms of naive T-cell depletion.
    Di Mascio M; Sereti I; Matthews LT; Natarajan V; Adelsberger J; Lempicki R; Yoder C; Jones E; Chow C; Metcalf JA; Sidorov IA; Dimitrov DS; Polis MA; Kovacs JA
    J Virol; 2006 Mar; 80(6):2665-74. PubMed ID: 16501076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune reconstitution in human immunodeficiency virus-infected children receiving highly active antiretroviral therapy: a cohort study.
    Johnston AM; Valentine ME; Ottinger J; Baydo R; Gryszowka V; Vavro C; Weinhold K; St Clair M; McKinney RE
    Pediatr Infect Dis J; 2001 Oct; 20(10):941-6. PubMed ID: 11642627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased thymic output after initiation of antiretroviral therapy in human immunodeficiency virus type 1-infected children in the Paediatric European Network for Treatment of AIDS (PENTA) 5 Trial.
    De Rossi A; Walker AS; Klein N; De Forni D; King D; Gibb DM
    J Infect Dis; 2002 Aug; 186(3):312-20. PubMed ID: 12134227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.